Skip to main content Accessibility help
×
Home
Hostname: page-component-5cfd469876-wkcxx Total loading time: 1.418 Render date: 2021-06-25T01:57:26.948Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true }

The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis

Published online by Cambridge University Press:  16 June 2016

Kirsten M. Fiest
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada O’Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada
Nathalie Jetté
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada O’Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada
Jodie I. Roberts
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada O’Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada
Colleen J. Maxwell
Affiliation:
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada Schools of Pharmacy and Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
Eric E. Smith
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
Sandra E. Black
Affiliation:
Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
Laura Blaikie
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Adrienne Cohen
Affiliation:
Department of Medicine, Cumming School of Medicine, Brenda Stafford Chair in Geriatric Medicine, University of Calgary, Calgary, Alberta, Canada
Lundy Day
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Jayna Holroyd-Leduc
Affiliation:
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada Department of Medicine, Cumming School of Medicine, Brenda Stafford Chair in Geriatric Medicine, University of Calgary, Calgary, Alberta, Canada
Andrew Kirk
Affiliation:
Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Dawn Pearson
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Tamara Pringsheim
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
Andres Venegas-Torres
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
David B. Hogan
Affiliation:
Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada Department of Medicine (Neurology), Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
Corresponding
Rights & Permissions[Opens in a new window]

Abstract

Introduction

Dementia is a common neurological condition affecting many older individuals that leads to a loss of independence, diminished quality of life, premature mortality, caregiver burden and high levels of healthcare utilization and cost. This is an updated systematic review and meta-analysis of the worldwide prevalence and incidence of dementia.

Methods

The MEDLINE and EMBASE databases were searched for relevant studies published between 2000 (1985 for Canadian papers) and July of 2012. Papers selected for full-text review were included in the systematic review if they provided an original population-based estimate for the incidence and/or prevalence of dementia. The reference lists of included articles were also searched for additional studies. Two individuals independently performed abstract and full-text review, data extraction, and quality assessment of the papers. Random-effects models and/or meta-regression were used to generate pooled estimates by age, sex, setting (i.e., community, institution, both), diagnostic criteria utilized, location (i.e., continent) and year of data collection.

Results

Of 16,066 abstracts screened, 707 articles were selected for full-text review. A total of 160 studies met the inclusion criteria. Among individuals 60 and over residing in the community, the pooled point and annual period prevalence estimates of dementia were 48.62 (CI95%: 41.98-56.32) and 69.07 (CI95%: 52.36-91.11) per 1000 persons, respectively. The respective pooled incidence rate (same age and setting) was 17.18 (CI95%: 13.90-21.23) per 1000 person-years, while the annual incidence proportion was 52.85 (CI95%: 33.08-84.42) per 1,000 persons. Increasing participant age was associated with a higher dementia prevalence and incidence. Annual period prevalence was higher in North America than in South America, Europe and Asia (in order of decreasing period prevalence) and higher in institutional compared to community and combined settings. Sex, diagnostic criteria (except for incidence proportion) and year of data collection were not associated with statistically significant different estimates of prevalence or incidence, though estimates were consistently higher for females than males.

Conclusions

Dementia is a common neurological condition in older individuals. Significant gaps in knowledge about its epidemiology were identified, particularly with regard to the incidence of dementia in low- and middle-income countries. Accurate estimates of prevalence and incidence of dementia are needed to plan for the health and social services that will be required to deal with an aging population.

Résumé

Prévalence et incidence de la démence : revue systématique et méta-analyse. Contexte: La démence est une maladie neurologique fréquente touchant de nombreuses personnes âgées. Elle est la cause de la perte de l’indépendance, d’une qualité de vie altérée, d’une mortalité prématurée et constitue un fardeau important pour les soignants. Elle entraîne une utilisation et un coût élevé de soins de santé par ces patients. Nous avons effectué une revue systématique et une méta-analyse à jour de la prévalence et de l’incidence de la démence à travers le monde. Méthodologie: Nous avons identifié les études pertinentes publiées entre 2000 (1985 pour les publications canadiennes) et juillet 2012 dans les bases de données MEDLINE et EMBASE. Les articles choisis pour un examen du texte intégral ont été inclus dans l’examen systématique s’ils fournissaient une estimation originale à l’échelle populationnelle de l’incidence et/ou de la prévalence de la démence. Nous avons également recherché des études additionnelles dans la liste de références incluse dans ces articles. Deux évaluateurs ont revu indépendamment les résumés et le texte intégral des publications ainsi que l’extraction des données et ils en ont évalué la qualité. Nous avons utilisé des modèles à effets aléatoires et/ou de méta-régression pour générer des estimations regroupées par âge, sexe, milieu (communauté, institution ou les deux), critères diagnostiques utilisés, lieu (continent), et année de collecte des données. Résultats: Parmi les 16 066 résumés revus, 707 articles ont été choisis pour une revue du texte intégral. En tout, 160 articles rencontraient les critères d’inclusion. Chez les individus de 60 ans et plus demeurant dans la communauté, les estimés regroupés de prévalence ponctuelle et annuelle de démence étaient de 48,62 (IC à 95%: 41,98 à 56,32) et 69,07 (IC à 95%: 52,36 à 91,11) par 1 000 personnes respectivement. Le taux d’incidence regroupée (même âge et contexte) était de 17,18 (IC à 95%: 13,90 à 21,23) par 1 000 personnes-années alors que la proportion d’incidence annuelle était de 52,85 (IC à 95%: 33,08 à 84,42) par 1 000. Un âge croissant des participants était associé à une prévalence et à une incidence plus élevées de démence. La prévalence annuelle pour une période donnée était plus élevée en Amérique du Nord qu’en Amérique du Sud, en Europe ou en Asie (en ordre décroissant de prévalence par période) et plus élevée dans un contexte institutionnel par rapport à la communauté et aux deux contextes combinés. Le sexe, les critères diagnostiques (sauf pour la proportion d’incidence) et l’année de la collecte des données n’étaient pas associés à des estimations de prévalence ou d’incidence significativement différentes au point de vue statistique, bien que les estimations étaient constamment plus élevées chez les femmes que chez les hommes. Conclusions: La démence est une maladie neurologique fréquente chez les individus plus âgés. Nous avons identifié d’importantes lacunes dans les connaissances sur l’épidémiologie, particulièrement en ce qui concerne l’incidence de la démence dans les pays à revenu faible et intermédiaire. Des estimations exactes de la prévalence et de l’incidence de la démence sont nécessaires pour la planification des services de santé et des services sociaux qui seront requis par une population vieillissante.

Type
Original Articles
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an open access article, distributed under the terms of the creative commons attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2016

Introduction

Dementia as defined in the Diagnostic and Statistical Manual of Mental Disorders–IV–Text Revision (DSM–IV–TR) is an acquired condition marked by impairments in memory and at least one other cognitive domain that are severe enough to cause significant limitations in social and/or occupational functioning and are not accounted for by a delirium or another Axis I disorder. 1 The DSM–5 renames dementia as major neurocognitive disorder. 2 For diagnosis there must be evidence of significant decline in at least one cognitive domain that is severe enough to interfere with independence in everyday activities. 2 Compared to earlier versions of the DSM, memory loss and impairments in multiple cognitive domains are no longer required features. 2 The various causes of dementia are categorized by their neuropathology, clinical features and/or presumed aetiology. The commoner ones encountered in middle-aged and older individuals are Alzheimer’s disease, vascular, Lewy body and frontotemporal dementia. They occur either as the sole cause of dementia (i.e., “pure” disease) or as combinations of two or more brain pathologies.

In addition to its significant personal toll, dementia is a major contributor to healthcare costs.Reference Wimo, Jonsson, Bond, Prince and Winblad 3 A 2013 report estimated that the annual cost of dementia in the United States was $157–215 billion US.Reference Hurd, Martorell, Delavande, Mullen and Langa 4 The total economic burden of dementia in Canada in 2008 was estimated to be $15 billion dollars. 5 The World Health Organization recognized dementia as a public health priority in 2012. 6 Age is the most important risk factor for dementia, with prevalence doubling every 5 years after 65 (from approximately 2-3% in those 65-69 to 30%+ among individuals over 80).Reference Li, Yan, Li, Chen, Zhang and Liu 7 - Reference Hendrie 12 It might also be more common among women, though the literature is inconsistent on this point.Reference Hendrie 12 , Reference Morris 13 High prevalence estimates are found in long-term care institutions,Reference Matthews and Dening 14 with the majority of those in these settings with moderate to severe dementia.Reference Fratiglioni, Forsell, Aguero Torres and Winblad 15 With societal aging, the burden of this condition will increase over the coming years. It is anticipated that the number suffering from dementia worldwide will double by 2030 and triple by 2050. 6

Whether the incidence and/or prevalence of dementia are changing over time is a key question about the epidemiology of this condition. Recent studies suggest that the age-adjusted incidence and/or prevalence of dementia in older populations could be changing over time but not in a consistent pattern, with estimates decreasing in high-income countries but increasing in middle-income ones. As an example of the former, investigators using data from the Rotterdam Study reported a nonsignificant decline in age-adjusted incidence rates between 1990 and 2010 among those 65+ (incidence rate ratio 0.75, CI95%: 0.56-1.02), possibly on the basis of better control of vascular risk factors. In parallel with an increase in the use of antithrombotics and lipid-lowering drugs over time, brain MRIs showed fewer lacunar infarcts.Reference Schrijvers, Verhaaren, Koudstaal, Hofman, Ikram and Breteler 16 It is plausible that improved cardiovascular risk management would be associated with a decreased incidence but stable prevalence (or a prevalence that is decreasing less markedly than incidence) of dementia as populations affected by dementia would live longer. Matthews et al.Reference Matthews, Arthur, Barnes, Bond, Jagger and Robinson 17 of the UK Medical Research Council Cognitive Function and Ageing Study (CFAS) found that the age- and sex-standardized prevalence of dementia among those 65+ years of age in three geographically defined areas of England was 65 per 1000 in 2011. This was significantly lower than the predicted rate based on 1991 data of 83 per 1000. There was a lower response rate in the 2011 study, but sensitivity analyses suggest that the estimates were robust to this. On the other hand, a systematic review of reports on the epidemiology of dementia in China found that the prevalence rose from 18 per 1,000 (65-69 years of age) and 421 per 1000 (95-99 years) to 26 per 1000 and 605 per 1000 respectively, between 1990 and 2010.Reference Chan, Wang, Wu, Liu, Theodoratou and Car 18 With societal aging worldwide, the number of individuals with dementia will increase, but there is uncertainty about what the actual number will be.Reference Larson and Langa 19 Aside from the importance of having accurate up-to-date figures for planning services to deal with the needs of those suffering from dementia, a better understanding of whether incidence and/or prevalence is changing would have important scientific and clinical consequences. For one thing, a decline would suggest that future rates are partially modifiable and that effectively dealing with modifiable risk factors might delay the onset if not entirely prevent the development of dementia as we age.

The specific objectives of this report are to: (1) provide estimates of the overall worldwide prevalence and incidence of dementia; (2) examine factors that underlie the heterogeneity of estimates (age, sex, setting [i.e., community, institution, both], diagnostic criteria, location of study [i.e., continent]); and (3) search for evidence of change over time in the prevalence and/or incidence of dementia. This study updates and extends the scope of previous reports on the epidemiology of this condition. 9 - Reference Matthews and Dening 14

Methods

This is one in a series of systematic reviews on the prevalence and incidence of priority neurological conditions funded by the Public Health Agency of Canada as part of the National Population Health Study of Neurological Conditions.Reference Caesar-Chavannes and MacDonald 20

Search Strategy

The systematic review and meta-analysis were conducted according to a predetermined protocol based on the PRISMA statement for systematic reviews and meta-analyses.Reference Moher, Liberati, Tetzlaff and Altman 21 Study authors with expertise in dementia and disease epidemiology and a research librarian with systematic review expertise developed the search strategy and terms (see Appendix A). The MEDLINE and EMBASE databases were searched from January 1985 to February 2011, with references exported and managed using EndNote X5. 22 The search was updated in July of 2012. Due to the availability of prior systematic reviews covering earlier time periods, only international studies published after 1999 were included in our systematic review. Because of the national focus of this project, Canadian studies published between 1985 and 1999 were also included in order to ensure that the Canadian Study of Health and Aging (a large and impactful national study on the epidemiology of dementia) was captured. 9 Articles had to be published in either English or French. The reference lists of included articles were manually searched for additional relevant references.

Study Selection

Two reviewers independently screened the titles and abstracts of all identified references to determine if they appeared to report original data on the prevalence or incidence of dementia. Studies clearly not population-based were excluded at this stage. Two reviewers independently examined the full-text articles identified in the first phase. For inclusion in the systematic review, articles had to meet the following criteria: (1) original research; (2) population-based; and (3) reported an incidence and/or prevalence estimate of dementia. Reviewers fluent in the language of the article examined the paper. Disagreements pertaining to the inclusion of articles were resolved by consensus and, if not reached, by involvement of a third study author.

Data Extraction and Study Quality

Two reviewers independently extracted and reached agreement on data from included articles using a standard data collection form. When multiple articles reported data from the same study population, the reviewers made a judgment as to the most comprehensive and accurate data available, which was then used in analyses. In cases where the studies reported on different timeframes or subgroups (e.g., by sex or age), all data were included. Demographic data recorded included age, sex, study setting (i.e., community, institution, both), and geographic location of study (i.e., continent, country). As not all studies reported on the mean or median age of participants, the youngest age of participants included in a study was employed in our analyses of age. The definitions/diagnostic criteria used for determining the presence of dementia were noted. Incidence and prevalence estimates of dementia from each study were recorded, along with any stratification by age, sex or year of data collection. The quality of the included studies was evaluated using an assessment toolReference Boyle 23 , Reference Loney, Chambers, Bennett, Roberts and Strafford 24 (Appendix B) that assessed such factors as sample representativeness, methods used to determine the presence of dementia, and statistical methods. Each study was given a quality score that ranged from 0 (lowest) to 8 (highest). ANOVA testing was done to determine if study quality varied by location of study (i.e., continent).

Data Synthesis and Analysis

The significance of the impact of age, sex, setting, diagnostic criteria, continent and year of data collection (i.e., when the study was done) on incidence and prevalence estimates was assessed using meta-regression. Age was examined using the youngest age of participants in the study as a continuous variable. Sex, setting, diagnostic criteria and location (i.e., continent) were examined as categorical variables. Changes over time were examined in three separate sensitivity analyses using study start, midpoint and end-years of data collection. All pooled estimates provided are restricted to studies reporting on people aged 60+, 65+ or 70+ to mitigate the potential confounding effects of age. Estimates were also stratified by study setting to limit potential confounding by disease severity. Finally, all estimates reporting on a period (e.g., period prevalence) were converted to annual estimates (e.g., annual prevalence) without restricting time-years.

To be eligible for inclusion in the meta-analysis, studies had to provide either the estimate with 95% confidence intervals (CI95%), or the number of dementia cases along with the sample size, so the prevalence or incidence estimates could be calculated. Additionally, a subgroup was only included in the subgroup analysis if more than one study was available for that subgroup.

To assess for significant between-study heterogeneity, the Cochrane Q statistic was calculated and I 2 was used to quantify the magnitude of between-study heterogeneity. All the pooled estimates and 95% confidence intervals were calculated using a random-effects model. Publication bias was investigated visually using funnel plots and statistically using Begg’sReference Begg and Mazumdar 25 and Egger’sReference Egger and Smith 26 tests.

All statistical analyses were carried out with R version 2.14. 27 The meta package was employed to produce the pooled estimates, forest plots and publication bias assessment.Reference Schwarzer 28 The metafor package was used to conduct the meta-regression using restricted maximum likelihood estimation.Reference Viechtbauer 29 A p value <0.05 was deemed to be statistically significant.

Results

Identification and Description of Studies

The search strategy yielded a total of 16,066 citations, including duplicates (8,743 from MEDLINE and 7,323 from EMBASE). A total of 707 articles were selected for full-text review (Figure 1), of which 547 were excluded (i.e., 230 were international studies published before 2000, 164 did not report an incidence or prevalence of dementia, 114 were not population-based, while 39 provided no original data). An additional four articles were identified by the updated search, while manual reference searching of included papers led to an additional 12 articles, though these papers did not report estimates of overall dementia, but rather only reported on dementia subtypes. Thus, a total of 160 studies were retained, the characteristics of which are shown in Tables 13. Twenty studies were not eligible for meta-analysis because they reported duplicate data or did not provide the information necessary to calculate an estimate. A total of 67 studies met the eligibility criteria (described earlier) for inclusion in the meta-analysis of those aged 60+, 65+ or 70+ years.

Figure 1 Study flow diagram.

Table 1 Studies Reporting on the Prevalence of Dementia

Table 2 Studies Reporting on the Incidence Rate of Dementia

Table 3 Studies Reporting on the Incidence Proportion of Dementia

Of the 160 total studies, 111 reported on prevalence, 9 , Reference Ebly, Parhad, Hogan and Fung 11 , Reference Matthews and Dening 14 , Reference Aguero Torres, von Strauss, Viitanen, Winblad and Fratiglioni 30 - Reference Zhou, Wu, Qi, Fan, Sun and Como 137 44 on incidence,Reference Corrada, Brookmeyer, Paganini-Hill, Berlau and Kawas 8 , 10 , Reference Andreasen, Blennow, Sjodin, Winblad and Svardsudd 138 - Reference Waite, Broe, Grayson and Creasey 179 and 5 on both.Reference Li, Yan, Li, Chen, Zhang and Liu 7 , Reference Lopez, Kuller, Fitzpatrick, Ives, Becker and Beauchamp 180 - Reference Zuliani, Cavalieri, Galvani, Volpato, Cherubini and Bandinelli 183 Sixty-three originated from Europe, 45 Asia, 43 North America, 7 South America, 5 Australia and 4 Africa (seven studies reported on data from more than one continent).

Prevalence of Dementia

Sixty-six articles reported on the point prevalence of dementia,Reference Li, Yan, Li, Chen, Zhang and Liu 7 , 9 , Reference Anttila, Helkala, Kivipelto, Hallikainen, Alhainen and Heinonen 32 , Reference Anttila, Helkala, Viitanen, Kåreholt, Fratiglioni and Winblad 33 , Reference Benedetti, Salviati, Filipponi, Manfredi, De Togni and Gomez Lira 36 , Reference Bermejo-Pareja, Benito-Leon, Vega, Olazarán, de Toledo and Díaz-Guzmán 38 , Reference Borroni, Alberici, Grassi, Rozzini, Turla and Zanetti 40 - Reference Corrada, Brookmeyer, Berlau, Paganini-Hill and Kawas 45 , Reference Dahl, Berg and Nilsson 47 , Reference de Jesus Llibre, Fernandez, Marcheco, Contreras, López and Otero 50 - Reference de Silva, Gunatilake and Smith 52 , Reference Di Carlo, Baldereschi, Amaducci, Maggi, Origoletto and Scarlato 54 - Reference Fujishima and Kiyohara 57 , Reference Graham, Rockwood, Beattie, Eastwood, Gauthier and Tuokko 64 , Reference Gurvit, Emre, Tinaz, Bilgic, Hanagasi and Sahin 67 - Reference Harvey, Skelton-Robinson and Rossor 69 , Reference Herrera, Caramelli, Silveira and Nitrini 71 , Reference Ikeda, Hokoishi, Maki, Nebu, Tachibana and Komori 73 - Reference Jacob, Kumar, Gayathri, Abraham and Prince 75 , Reference Jitapunkul, Chansirikanjana and Thamarpirat 77 - Reference Kahana, Galper, Zilber and Korczyn 80 , Reference Kivipelto, Helkala, Laakso, Hänninen, Hallikainen and Alhainen 82 , Reference Kivipelto, Helkala, Laakso, Laakso, Hallikainen and Alhainen 83 , Reference Livingston, Leavey, Kitchen, Manela, Sembhi and Katona 88 - Reference Llibre Rodriguez, Ferri, Acosta, Guerra, Huang and Jacob 90 , Reference Mathuranath, Cherian, Mathew, Kumar, George and Alexander 97 , Reference Meguro, Ishii, Yamaguchi, Ishizaki, Shimada and Sato 98 , Reference Nabalamba and Patten 101 - Reference Nunes, Silva, Cruz, Roriz, Pais and Silva 103 , Reference Plassman, Langa, Fisher, Heeringa, Weir and Ofstedal 105 - Reference Riedel-Heller, Busse, Aurich, Matschinger and Angermeyer 109 , Reference Rosenblatt, Samus, Steele, Baker, Harper and Brandt 112 - Reference Sanderson, Benjamin, Lane, Cornman and Davis 115 , Reference Sekita, Ninomiya, Tanizaki, Doi, Hata and Yonemoto 117 , Reference Shaji, Bose and Verghese 120 , Reference Silver, Jilinskaia and Perls 121 , Reference Spada, Stella, Calabrese, Bosco, Anello and Guéant-Rodriguez 123 - Reference Suh, Kim and Cho 125 , Reference Vas, Pinto, Panikker, Noronha, Deshpande and Kulkarni 127 - Reference Wancata, Borjesson-Hanson, Ostling, Sjogren and Skoog 131 , Reference Wertman, Brodsky, King, Bentur and Chekhmir 133 , Reference Yamada, Hattori, Miura, Tanabe and Yamori 135 , Reference Zhou, Wu, Qi, Fan, Sun and Como 137 , Reference Meguro, Ishii, Kasuya, Akanuma, Meguro and Kasai 181 with 29 eligible for inclusion (i.e., provided an estimate with 95% confidence intervals, etc.) in the meta-analysis of those including populations aged 60+, 65+ or 70+ years. 9 , Reference Anttila, Helkala, Kivipelto, Hallikainen, Alhainen and Heinonen 32 , Reference Anttila, Helkala, Viitanen, Kåreholt, Fratiglioni and Winblad 33 , Reference Bermejo-Pareja, Benito-Leon, Vega, Olazarán, de Toledo and Díaz-Guzmán 38 , Reference Bottino, Azevedo, Tatsch, Hototian, Moscoso and Folquitto 41 - Reference Chen, Chiu, Tang, Chiu, Chang and Su 43 , Reference de Jesus Llibre, Fernandez, Marcheco, Contreras, López and Otero 50 - Reference de Silva, Gunatilake and Smith 52 , Reference Di Carlo, Baldereschi, Amaducci, Maggi, Origoletto and Scarlato 54 , Reference Gurvit, Emre, Tinaz, Bilgic, Hanagasi and Sahin 67 , Reference Herrera, Caramelli, Silveira and Nitrini 71 , Reference Ikeda, Hokoishi, Maki, Nebu, Tachibana and Komori 73 , Reference Jacob, Kumar, Gayathri, Abraham and Prince 75 , Reference Jitapunkul, Kunanusont, Phoolcharoen and Suriyawongpaisal 78 , Reference Kivipelto, Helkala, Laakso, Hänninen, Hallikainen and Alhainen 82 , Reference Llibre Rodriguez, Valhuerdi, Sanchez, Reyna, Guerra and Copeland 89 , Reference Llibre Rodriguez, Ferri, Acosta, Guerra, Huang and Jacob 90 , Reference Meguro, Ishii, Yamaguchi, Ishizaki, Shimada and Sato 98 , Reference Rovio, Kareholt, Helkala, Viitanen, Winblad and Tuomilehto 113 , Reference Shaji, Bose and Verghese 120 , Reference Spada, Stella, Calabrese, Bosco, Anello and Guéant-Rodriguez 123 - Reference Suh, Kim and Cho 125 , Reference Wada-Isoe, Uemura, Suto, Doi, Imamura and Hayashi 129 , Reference Wancata, Borjesson-Hanson, Ostling, Sjogren and Skoog 131 , Reference Yamada, Hattori, Miura, Tanabe and Yamori 135 , Reference Meguro, Ishii, Kasuya, Akanuma, Meguro and Kasai 181

In all studies reporting on the point prevalence of dementia (n=66), the majority of studies used a single data source to identify cases (n=51). These included door-to-door surveys (n=16), registry studies (n=10), other sources (n=10), administrative databases (n=3), mail surveys (n=1) and hospital/clinic reviews (n=1). It was not possible to determine the data source in 10 of these studies. A total of 15 studies used multiple data sources. Half (n=33) of the 66 included studies used a single diagnostic method, including a standardized assessment by a healthcare professional (n=26), administrative data codes (n=2), medical chart review (n=2), other sources (n=2) and self-report of a physician diagnosis (n=1).

The pooled point prevalence of dementia per 1000 in 23 community-setting studies was 48.62 (CI95%: 41.98-56.32), while the pooled point prevalence in combined community and institution settings (n=5) was 57.98 (CI95%: 42.02-80.00) (Figure 2). The point prevalence of dementia within institutions (n=2) was 581.09 (CI95%: 558.48-604.61) per 1000. Among the 29 eligible studies reporting on the point prevalence of dementia, estimates ranged from 8.00 per 1000 in a community-only study from IndiaReference Jacob, Kumar, Gayathri, Abraham and Prince 75 to 592.51 per 1000 in an institutional sample from Taiwan.Reference Chen, Chiu, Tang, Chiu, Chang and Su 43

Figure 2 Pooled point prevalence of dementia.

Fifty articles reported on the period prevalence for dementia,Reference Ebly, Parhad, Hogan and Fung 11 , Reference Matthews and Dening 14 , Reference Aguero Torres, von Strauss, Viitanen, Winblad and Fratiglioni 30 , Reference Andersen-Ranberg, Vasegaard and Jeune 31 , Reference Arslantas, Ozbabalik, Metintas, Ozkan, Kalyoncu and Ozdemir 34 , Reference Banerjee, Mukherjee, Dutt, Shekhar and Hazra 35 , Reference Bennett, Piguet, Grayson, Creasey, Waite and Broe 37 , Reference Borjesson-Hanson, Edin, Gislason and Skoog 39 , Reference Cristina, Nicolosi, Hauser, Leite, Gerosa and Nappi 46 , Reference Das, Biswas, Roy, Bose, Roy and Banerjee 48 , Reference Das, Biswas, Roy, Banerjee, Mukherjee and Raut 49 , Reference Demirovic, Prineas, Loewenstein, Bean, Duara and Sevush 53 , Reference Galasko, Salmon, Gamst, Olichney, Thal and Silbert 58 - Reference Gourie-Devi, Gururaj, Satishchandra and Subbakrishna 63 , Reference Guerchet, M’Belesso, Mouanga, Bandzouzi, Tabo and Houinato 65 , Reference Gureje, Ogunniyi and Kola 66 , Reference Helmer, Peres, Letenneur, Guttiérez-Robledo, Ramaroson and Barberger-Gateau 70 , Reference Ikeda, Fukuhara, Shigenobu, Hokoishi, Maki and Nebu 72 , Reference Jhoo, Kim, Huh, Lee, Park and Lee 76 , Reference Kim, Jeong, Chun and Lee 81 , Reference Landi, Russo, Cesari, Barillaro, Onder and Zamboni 84 - Reference Li, Rhew, Shofer, Kukull, Breitner and Peskind 87 , Reference Lovheim, Karlsson and Gustafson 91 - Reference Martens, Fransoo, Burland, Burchill, Prior and Ekuma 96 , Reference Mehlig, Skoog, Guo, Schütze, Gustafson and Waern 99 , Reference Molero, Pino-Ramirez and Maestre 100 , Reference Perkins, Hui, Ogunniyi, Gureje, Baiyewu and Unverzagt 104 , Reference Riedel-Heller, Schork, Matschinger and Angermeyer 110 , Reference Rockwood, Wentzel, Hachinski, Hogan, MacKnight and McDowell 111 , Reference Scazufca, Menezes, Vallada, Crepaldi, Pastor-Valero and Coutinho 116 , Reference Senanarong, Jamjumrus, Harnphadungkit, Vannasaeng, Udompunthurak and Prayoonwiwat 118 , Reference Senanarong, Poungvarin, Sukhatunga, Prayoonwiwat, Chaisewikul and Petchurai 119 , Reference Sousa, Ferri, Acosta, Albanese, Guerra and Huang 122 , Reference van Exel, de Craen, Gussekloo, Houx, Bootsma-van der Wiel and Macfarlane 126 , Reference Wangtongkum, Sucharitkul, Silprasert and Inthrachak 132 , Reference Xu, Qiu, Gatz, Pedersen, Johansson and Fratiglioni 134 , Reference Zhao, Zhou, Ding, Guo and Hong 136 , Reference Lopez, Kuller, Fitzpatrick, Ives, Becker and Beauchamp 180 , Reference Phung, Waltoft, Kessing, Mortensen and Waldemar 182 , Reference Zuliani, Cavalieri, Galvani, Volpato, Cherubini and Bandinelli 183 with 18 eligible for inclusion (see Methods section) in the meta-analysis.Reference Matthews and Dening 14 , Reference Cristina, Nicolosi, Hauser, Leite, Gerosa and Nappi 46 , Reference Das, Biswas, Roy, Bose, Roy and Banerjee 48 , Reference Galasko, Salmon, Gamst, Olichney, Thal and Silbert 58 - Reference Gavrila, Antunez, Tormo, Carles, García Santos and Parrilla 61 , Reference Gureje, Ogunniyi and Kola 66 , Reference Jhoo, Kim, Huh, Lee, Park and Lee 76 , Reference Kim, Jeong, Chun and Lee 81 , Reference Langa, Plassman, Wallace, Herzog, Heeringa, Ofstedal and Burke 85 - Reference Li, Rhew, Shofer, Kukull, Breitner and Peskind 87 , Reference Magaziner, German, Zimmerman, Hebel, Burton and Gruber-Baldini 93 , Reference Scazufca, Menezes, Vallada, Crepaldi, Pastor-Valero and Coutinho 116 , Reference Sousa, Ferri, Acosta, Albanese, Guerra and Huang 122 , Reference Xu, Qiu, Gatz, Pedersen, Johansson and Fratiglioni 134 , Reference Lopez, Kuller, Fitzpatrick, Ives, Becker and Beauchamp 180 , Reference Zuliani, Cavalieri, Galvani, Volpato, Cherubini and Bandinelli 183

In the 50 studies that reported on the period prevalence of dementia, the majority (n=39) used a single source of the study population, including door-to-door surveys (n=21), registries (n=8), other sources (n=4), administrative databases (n=2) and a census (n=1). It was not possible to determine the data source in three studies. Twenty-six of the 50 included studies used a single methodology to identify cases—the majority used a standardized assessment by a health professional (n=22), followed by administrative data codes (n=3). It was not possible to determine how they identified cases in one study.

In community-only settings (n=14), the pooled annual period prevalence per 1000 was 69.07 (CI95%: 52.36-91.11) compared to 72.66 (CI95%: 42.96-122.91) in combined community and institution samples (n=2) and 533.24 per 1000 within institutions (n=2) (Figure 3). Among individual studies, the annual period prevalence estimates ranged from 7.92 in a community-only sample in IndiaReference Das, Biswas, Roy, Bose, Roy and Banerjee 48 to 593.00 per 1000 in an institutional study from the United Kingdom.Reference Matthews and Dening 14

Figure 3 Pooled period prevalence of dementia.

Incidence of Dementia

Seventeen studies reported on the incidence proportion of dementia, 10 , Reference Andreasen, Blennow, Sjodin, Winblad and Svardsudd 138 - Reference Benito-Leon, Bermejo-Pareja, Vega and Louis 140 , Reference Cornelius, Fastbom, Winblad and Viitanen 142 , Reference Forti, Pisacane, Rietti, Lucicesare, Olivelli and Mariani 146 , Reference Ganguli, Dodge, Chen, Belle and DeKosky 148 , Reference Hendrie, Ogunniyi, Hall, Baiyewu, Unverzagt and Gureje 150 , Reference Kawas, Gray, Brookmeyer, Fozard and Zonderman 151 , Reference Knopman, Rocca, Cha, Edland and Kokmen 155 , Reference Kuller, Lopez, Jagust, Becker, DeKosky and Lyketsos 157 , Reference Lopez, Kuller, Becker, Jagust, DeKosky and Fitzpatrick 159 , Reference Miech, Breitner, Zandi, Khachaturian, Anthony and Mayer 165 , Reference Piguet, Grayson, Creasey, Bennett, Brooks and Waite 167 , Reference Seshadri, Beiser, Selhub, Jacques, Rosenberg and D’Agostino 175 , Reference Simons, Simons, McCallum and Friedlander 176 , Reference Zuliani, Cavalieri, Galvani, Volpato, Cherubini and Bandinelli 183 with 10 eligible for inclusion in the meta-analysis of those aged 60+, 65+ or 70+ years.Reference Arai, Katsumata, Konno and Tamashiro 139 , Reference Benito-Leon, Bermejo-Pareja, Vega and Louis 140 , Reference Ganguli, Dodge, Chen, Belle and DeKosky 148 , Reference Hendrie, Ogunniyi, Hall, Baiyewu, Unverzagt and Gureje 150 , Reference Kuller, Lopez, Jagust, Becker, DeKosky and Lyketsos 157 , Reference Lopez, Kuller, Becker, Jagust, DeKosky and Fitzpatrick 159 , Reference Miech, Breitner, Zandi, Khachaturian, Anthony and Mayer 165 , Reference Seshadri, Beiser, Selhub, Jacques, Rosenberg and D’Agostino 175 , Reference Simons, Simons, McCallum and Friedlander 176 , Reference Zuliani, Cavalieri, Galvani, Volpato, Cherubini and Bandinelli 183 All were from community settings. Of 17 studies reporting on the incidence proportion of dementia, 16 used a single methodology to recruit participants, most frequently door-to-door survey (n=5). Other approaches included administrative databases (n=3), registries (n=2), hospital/clinic chart reviews (n=1) and other methods (n=1). It was not possible to determine the data source in two cases, and one study used another methodology. In order to ascertain cases, most studies (n=11) used multiple sources of data (e.g., healthcare professional diagnosis and imaging test results). Six studies based the case ascertainment purely on a healthcare professional assessment.

A random-effects model found that the overall pooled incidence proportion of dementia per 1000 was 52.85 (CI95%: 33.08-84.42) (Figure 4). Among the included studies, incidence proportion estimates ranged from 8.70 in a Japanese studyReference Arai, Katsumata, Konno and Tamashiro 139 to 142.22 per 1000 in a U.S. one.Reference Kuller, Lopez, Jagust, Becker, DeKosky and Lyketsos 157

Figure 4 Pooled incidence proportion of dementia.

Thirty-two studies reported on the incidence rate of dementia,Reference Li, Yan, Li, Chen, Zhang and Liu 7 , Reference Corrada, Brookmeyer, Paganini-Hill, Berlau and Kawas 8 , Reference Bermejo-Pareja, Benito-Leon, Vega, Medrano and Roman 141 , Reference Di Carlo, Baldereschi, Amaducci, Lepore, Bracco and Maggi 143 - Reference Fitzpatrick, Kuller, Ives, Lopez, Jagust and Breitner 145 , Reference Fuhrer, Dufouil and Dartigues 147 , Reference Garre-Olmo, Genis Batlle, del Mar Fernandez, Marquez Daniel, de Eugenio Huélamo and Casadevall 149 , Reference Knopman, Petersen, Cha, Edland and Rocca 152 - Reference Knopman, Rocca, Cha, Edland and Kokmen 154 , Reference Kukull, Higdon, Bowen, McCormick, Teri and Schellenberg 156 , Reference Larrieu, Letenneur, Helmer, Dartigues and Barberger-Gateau 158 , Reference Lopez-Pousa, Vilalta-Franch, Llinas-Regla, Garre-Olmo and Roman 160 - Reference Mercy, Hodges, Dawson, Barker and Brayne 164 , Reference Nitrini, Caramelli, Herrera, Bahia, Caixeta and Radanovic 166 , Reference Polvikoski, Sulkava, Rastas, Sutela, Niinistö and Notkola 168 - Reference Samieri, Feart, Letenneur, Dartigues, Pérès and Auriacombe 174 , Reference Tyas, Tate, Wooldrage, Manfreda and Strain 177 - Reference Phung, Waltoft, Kessing, Mortensen and Waldemar 182 with nine eligible for inclusion in the meta-analysis.Reference Bermejo-Pareja, Benito-Leon, Vega, Medrano and Roman 141 , Reference Di Carlo, Baldereschi, Amaducci, Lepore, Bracco and Maggi 143 , Reference Fitzpatrick, Kuller, Ives, Lopez, Jagust and Breitner 145 , Reference Kukull, Higdon, Bowen, McCormick, Teri and Schellenberg 156 , Reference Larrieu, Letenneur, Helmer, Dartigues and Barberger-Gateau 158 , Reference Nitrini, Caramelli, Herrera, Bahia, Caixeta and Radanovic 166 , Reference Ravaglia, Forti, Maioli, Martelli, Servadei and Brunetti 170 , Reference Samieri, Feart, Letenneur, Dartigues, Pérès and Auriacombe 174 , Reference Tyas, Tate, Wooldrage, Manfreda and Strain 177 , Reference Vermeer, Prins, den Heijer, Hofman, Koudstaal and Breteler 178 The majority of the 32 studies reporting on the incidence rate of dementia used a single source to identify their population (n=21)—these sources were door-to-door surveys (n=8), registries (n=6), administrative databases (n=3) and other sources in two studies. It was not possible to determine the data source in another two studies. Fifteen of the 32 studies used a single methodology to identify cases, including a standardized assessment by a health professional (n=10), chart review (n=4) and administrative data codes (n=1). The remaining 17 used multiple sources.

In community-only settings, the pooled incidence rate of dementia per 1000 person-years was 17.18 (CI95%: 13.90-21.23). In a single combined community and institution study, the estimated incidence rate was 13.33 per 1000 person-years (CI95%: 11.18-15.89) (there were no institution-only studies) (Figure 5). The incidence rate estimates ranged from 8.11 per 1000 person-years in a community-only study from the NetherlandsReference Vermeer, Prins, den Heijer, Hofman, Koudstaal and Breteler 178 to 37.80 per 1000 person-years in a community-only study from Italy.Reference Ravaglia, Forti, Maioli, Martelli, Servadei and Brunetti 170

Figure 5 Pooled incidence rate of dementia.

Sources of Heterogeneity

In our exploration of sources of heterogeneity, we restricted our analyses to studies reporting on individuals 60+, 65+ or 70+ in order to minimize the potential confounding effects of age. Because of the small number of studies, we could not explore the interaction between the potential sources of heterogeneity.

Age

Using the youngest-aged person in a study to assess this characteristic, a series of meta-regression analyses revealed that increasing age was significantly associated (p<0.001) with a higher prevalence or incidence of dementia.

Sex

Meta-regression showed no statistically significant differences between the sexes on any of our estimates, though estimates were consistently higher in females (p>0.05).

Setting

Point Prevalence. Estimates from institution-only settings were significantly higher than those from community-only and combined community and institution settings (p<0.0001). The difference in point prevalence in combined community and institutional settings (57.98 [CI95%: 42.02-80.00] per 1000) compared to community-only ones (48.62 [CI95%: 41.98-56.32] per 1000) was not statistically significant (p=0.33).

Annual Period Prevalence. No significant difference in pooled estimates of annual period prevalence was found between community-only (70.86 [CI95%: 55.78-90.03] per 1000) and combined community and institution settings (72.66 [CI95%: 42.96-122.91] per 1000). Annual period prevalence was significantly higher in institution-only settings (533.24 [CI95%: 435.25-653.28] per 1000, p<0.0001).

Incidence Proportion and Rate. Estimates for incidence proportion were derived solely from community-only settings. There was an insufficient number of studies from non-community settings to assess incidence rate.

Diagnostic Criteria

Comparisons were restricted to studies done in the same setting (community-only, community and institution, institution-only) and where the specific criteria were utilized by more than one study.

Point Prevalence. In community-only settings, there were only sufficient studies for analysis using either DSM–IV (n=16) or DSM–III–R (n=4) diagnostic criteria. There was no significant difference (p=0.33) in the pooled point prevalence estimates between these two criteria.

DSM–IV (n=3) and DSM–III–R (n=2) were the most commonly used criteria in combined community and institutional settings (and the only criteria eligible for inclusion). There was no significant difference (p=0.30) in pooled point prevalence estimates between them.

Annual Period Prevalence. Community-only studies eligible for this analysis employed either DSM–III–R (n=4) or the DSM–IV (n=11) criteria. There was no significant difference (p=0.49) between their estimates for the annual period prevalence.

Incidence Proportion and Rate. In community-only settings, the most commonly used criteria to determine incidence proportion were the DSM–III–R (n=3) and the DSM–IV (n=4). These pooled estimates of the incidence proportion differed significantly from each other, with estimates higher in DSM–IV studies (p=0.03). The only available study for incidence rate used DSM–III–R criteria.

Region

Point Prevalence. Among community-only studies, there were no significant differences in pooled estimates between Asia (n=12), Europe (n=7), North America (n=4) and South America (n=3). There were no differences between Europe (n=3) and North America (n=2) in the pooled point prevalence of dementia among community and institutional studies. The institution-only estimates from North America (n=1) and Asia (n=1) were very similar.

Annual Period Prevalence. There were estimates from four continents for the annual pooled period prevalence of dementia in community-only studies (Asia [n=6], Europe [n=3], North America [n=4], South America [n=2]). The pooled North American annual estimate (129.81 [CI95%: 104.73-160.91] per 1000) was significantly higher than that of Asia (45.24 [CI95%: 25.91-78.99] per 1000), Europe (47.98 [CI95%: 31.95-72.07] per 1000) and South America (69.63 [CI95%: 53.28-91.00] per 1000).

Incidence Proportion. There were community-only studies from two continents (Europe [n=2], North America [n=5]). The estimates from North America (75.48 [CI95%: 47.37-120.28] per 1000) and Europe (64.75 [28.37-147.79] per 1000) were not significantly different (p=0.75).

Incidence Rate. In community-only studies, there were estimates from two continents (Europe [n=5], North America [n=3]). There were no significant differences (p=0.18) in the estimates among them.

Year of Data Collection

Meta-regression revealed that there were no significant changes over time in the incidence or prevalence of dementia.

Publication Bias

There was no evidence of publication bias with either Begg’s or Egger’s test for point prevalence (p>0.05). Evidence of publication bias was found for the period prevalence on both Begg’s and Egger’s tests where smaller studies of the effect were potentially missing (p<0.0001). For the incidence rate, there was no evidence of publication bias on either the Begg’s (p>0.05) or Egger’s (p>0.05) test. Evidence of publication bias was found for the incidence proportion using the Egger’s (p=0.037) but not the Begg’s (p>0.05) test.

Study Quality

The median study quality score was 6 (range 2-8). ANOVA testing did not reveal any statistical difference in study quality by continent (see Table 4 for details).

Table 4 Quality assessment scores of dementia incidence and prevalence studies

*Note: NR= Not reported; NC= Not clear

Discussion

This systematic review and meta-analysis of the global incidence and prevalence of dementia provides overall estimates as well as subgroup analyses by age, sex, setting, diagnostic criteria, study location (e.g., continent) and year of data collection. While, as expected, the incidence and prevalence of dementia rose with increasing age, no significant differences in the pooled estimates between men and women were found. There was a non-significant trend for community-only settings to have a lower prevalence than combined community plus institution studies, while the prevalence estimate was significantly higher in institution-only settings. Other than for incidence proportion, there were no significant differences between studies using the DSM–III–R and DSM–IV diagnostic criteria. North American pooled period prevalence and incidence proportion estimates were the highest, while those from Asia were lowest. Estimates of prevalence and incidence did not change over time. Unfortunately, we were not able to show the decline found in some recent studies.Reference Schrijvers, Verhaaren, Koudstaal, Hofman, Ikram and Breteler 16 , Reference Matthews, Arthur, Barnes, Bond, Jagger and Robinson 17 This could have a significant impact on the future burden of this condition. As noted earlier, with societal aging it is anticipated that the number of people with dementia worldwide will double by 2030 and triple by 2050. 6 A decline in prevalence as seen in the CFASReference Matthews, Arthur, Barnes, Bond, Jagger and Robinson 17 would lower estimates of future costs for dealing with dementia in the United States by approximately 40%.Reference Hurd, Martorell and Langa 184

The present study updates the body of literature on the epidemiology of dementia. Compared to other systematic reviews, a broader perspective was generally taken. For example, a recent systematic review on the prevalence of dementia was restricted to persons diagnosed only with DSM–IV and ICD–10 criteria and did not assess heterogeneity by any factor other than geographic region,Reference Prince, Bryce, Albanese, Wimo, Ribeiro and Ferri 185 or focused only on China or Asia and/or did not perform a systematic review or meta-analysis.Reference Catindig, Venketasubramanian, Ikram and Chen 186 - Reference Zhang, Xu, Nie, Lei, Wu and Zhang 188

Erkinjuntti and colleaguesReference Erkinjuntti, Ostbye, Steenhuis and Hachinski 189 examined the effect of different diagnostic criteria on the prevalence of dementia in a large population-based cohort and found widely varying estimates (e.g., 3.1% using the ICD–10 classification system versus 29.1% with DSM–III criteria). More modest differences were found when DSM–III–R and DSM–IV criteria were compared (17.3 and 13.7%, respectively). In this report, we had a limited ability to explore the influence of diagnostic criteria but found evidence that DSM–III–R and DSM–IV criteria produced similar results, other than for incidence proportion.

Prior research has suggested that there might be significant regional differences in the prevalence and incidence of dementia.Reference Prince, Bryce, Albanese, Wimo, Ribeiro and Ferri 185 Unfortunately, there are major limitations in the available data, such as a lack of nationally representative studies in a number of large countries, few reports from some regions of the world (e.g., Sub-Saharan Africa), and the marked heterogeneity seen between countries within a geographic region (i.e., studies carried out in one or two countries cannot be safely generalized to all nations within a specific region). Study quality did not vary by continent in the present analyses. The lowest estimates of period prevalence obtained from Asia are consistent with other recent systematic reviews where the incidence and/or prevalence of other neurodegenerative conditions (i.e., Parkinson’s and Huntington’s disease) have been reported to be lower in Asia.Reference Pringsheim, Jette, Frolkis and Steeves 190 , Reference Pringsheim, Wiltshire, Day, Dykeman, Steeves and Jette 191 A number of factors could account for these differences, including population genetics, exposure to environmental risk factors, differing life expectancy, and variations in case ascertainment due to the amount of stigma associated with certain conditions resulted in underreporting.

The strength of the conclusions that can be drawn from this study is limited by a number of factors. First, the quality of the included studies was variable and at times less than desired (e.g., no reporting of response rates or nonresponder characteristics). Second, significant heterogeneity was present among all estimates of prevalence and incidence. This was likely driven by the differing populations studied and methods used. There was evidence of publication bias for the incidence proportion and period prevalence of dementia, suggesting that there may be unpublished studies reporting differing results. Finally, some studies did not provide the specific data (e.g., proportion with CI95%, numerator and denominator, etc.) necessary to include them in the meta-analyses. To improve the comparability of studies and comprehensiveness of future meta-analyses in this area, an effort should be made to standardize study procedures and reporting.

In conclusion, dementia is a common neurological condition in older individuals. Significant gaps in knowledge about its epidemiology were identified. For example, there are few studies examining the incidence of dementia in low- and middle-income countries, where the disruptive impact of an aging population may be greatest in view of limited resources. Future research should also focus on assessing the impact of utilizing DSM–5 diagnostic criteria for major neurocognitive disorders on estimates, examining differences in rates among subgroups within a larger study population, where appropriate, and further assessing dementia in a variety of settings and geographic regions.

Acknowledgements

We would like thank Ms. Diane Lorenzetti, librarian at the University of Calgary, who guided the development of the search strategy for this systematic review. Our study is part of the National Population Health Study of Neurological Conditions. We acknowledge the membership of the Neurological Health Charities Canada and the Public Health Agency of Canada for their contribution to the success of this initiative. Funding for the study was provided by the Public Health Agency of Canada. The opinions expressed in this publication are those of the authors/researchers and do not necessarily reflect the official views of the Public Health Agency of Canada.

Disclosures

Kirsten Fiest, Jodie Roberts, Colleen Maxwell, Sandra Black, Laura Blaikie, Adrienne Cohen, Lundy Day, Jayna Holroyd-Leduc, Andrew Kirk, Dawn Pearson and Andres Venegas-Torres have nothing to disclose.

Nathalie Jetté has the following disclosures: Public Health Agency of Canada, Principal Investigator, research support; Canada Research Chair, Researcher, research support; Alberta Innovates Health Solutions, Researcher, research support.

David B. Hogan holds the Brenda Strafford Foundation Chair in Geriatric Medicine, though receives no salary support from this.

Statement of Authorship

KMF, NJ, JIR, CJM, TP and DBH contributed to study conception and design. KMF, NJ, JIR, CJM, EES, SEB, LB, AC, LD, JH, AK, DP, AV and DBH contributed to the acquisition of data. KMF conducted the data analysis. KMF, NJ, JIR, CJM, EES and DBH participated in the interpretation of study data. All authors participated in critically revising the manuscript for important intellectual content and gave final approval for the submission of this manuscript and any further submissions of this work.

Supplementary Material

To view the supplementary material that exist for this study (Appendix A and B), please visit http://dx.doi.org/10.1017/cjn.2016.18.

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders–IV–Text Revision. Washington, DC: American Psychiatric Association; 1994.Google Scholar
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders–5. Washington, DC: American Psychiatric Association; 2013.Google ScholarPubMed
3. Wimo, A, Jonsson, L, Bond, J, Prince, M, Winblad, B, Alzheimer Disease International. The worldwide economic impact of dementia 2010. Alzheimers Dement. 2013;9:1-11 e13.CrossRefGoogle ScholarPubMed
4. Hurd, MD, Martorell, P, Delavande, A, Mullen, KJ, Langa, KM. Monetary costs of dementia in the United States. N Engl J Med. 2013;368:1326-1334.CrossRefGoogle ScholarPubMed
5. Alzheimer Society of Canada. Rising Tide: The Impact of Dementia on Canadian Society. Toronto, ON: Alzheimer Society of Canada; 2010.Google Scholar
6. World Health Organization. Dementia: A Public Health Priority. Geneva: World Health Organization; 2012.Google Scholar
7. Li, S, Yan, F, Li, G, Chen, C, Zhang, W, Liu, J, et al. Is the dementia rate increasing in Beijing? Prevalence and incidence of dementia 10 years later in an urban elderly population. Acta Psychiatr Scand. 2007;115:73-79.CrossRefGoogle Scholar
8. Corrada, MM, Brookmeyer, R, Paganini-Hill, A, Berlau, D, Kawas, CH. Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol. 2010;67:114-121.CrossRefGoogle ScholarPubMed
9. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ. 1994;150:899-913.Google ScholarPubMed
10. The Canadian Study of Health and Aging Working Group. The incidence of dementia in Canada. Neurology. 2000;55:66-73.CrossRefGoogle ScholarPubMed
11. Ebly, EM, Parhad, IM, Hogan, DB, Fung, TS. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology. 1994;44:1593-1600.CrossRefGoogle ScholarPubMed
12. Hendrie, HC. Epidemiology of dementia and Alzheimer’s disease. Am J Geriatr Psychiatry. 1998;6:S3-18.CrossRefGoogle ScholarPubMed
13. Morris, JC. Dementia update 2005. Alzheimer Dis Assoc Disord. 2005;19:100-117.CrossRefGoogle ScholarPubMed
14. Matthews, FE, Dening, T, UK Medical Research Council Cognitive Function and Ageing Study. Prevalence of dementia in institutional care. Lancet. 2002;360:225-226.CrossRefGoogle ScholarPubMed
15. Fratiglioni, L, Forsell, Y, Aguero Torres, H, Winblad, B. Severity of dementia and institutionalization in the elderly: prevalence data from an urban area in Sweden. Neuroepidemiol. 1994;13:79-88.CrossRefGoogle ScholarPubMed
16. Schrijvers, E, Verhaaren, B, Koudstaal, P, Hofman, A, Ikram, MB, Breteler, MM. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78:1456-1463.CrossRefGoogle ScholarPubMed
17. Matthews, FE, Arthur, A, Barnes, LE, Bond, J, Jagger, C, Robinson, L, et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II. Lancet. 2013;382:1405-1412.CrossRefGoogle ScholarPubMed
18. Chan, KY, Wang, W, Wu, JJ, Liu, L, Theodoratou, E, Car, J, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013;381:2016-2023.CrossRefGoogle ScholarPubMed
19. Larson, EB, Langa, KM. Aging and incidence of dementia: a critical question. Neurology. 2012;78:1452-1453.CrossRefGoogle ScholarPubMed
20. Caesar-Chavannes, C, MacDonald, S. Cross-Canada Forum: National Population Health Study of Neurological Conditions in Canada. Chronic Dis Inj Can. 2013;33:188-191.Google Scholar
21. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefGoogle Scholar
22. Endnote X5. New York: Thompson Reuters, 2011. Available from http://endnote.com/downloads/available-updates.Google Scholar
23. Boyle, MH. Guidelines for evaluating prevalence studies. Evid Based Ment Health. 1998;1:37-39.CrossRefGoogle Scholar
24. Loney, PL, Chambers, LW, Bennett, KJ, Roberts, JG, Strafford, PW. Critical appraisal of health literature: prevalence or incidence of a health problem. Chronic Dis Can. 1998;19:170-176.Google ScholarPubMed
25. Begg, C, Mazumdar, M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.CrossRefGoogle ScholarPubMed
26. Egger, M, Smith, G. Bias in meta-analysis detected by simple, graphical test. BMJ. 1997;315:629-634.CrossRefGoogle ScholarPubMed
27. R: A Language and Environment for Statistical Computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2011.Google Scholar
28. Schwarzer, G. meta: Meta-Analysis with R. R package version 16-1 2010.Google Scholar
29. Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J Stat Soft. 2010;36:1-48.CrossRefGoogle Scholar
30. Aguero Torres, H, von Strauss, E, Viitanen, M, Winblad, B, Fratiglioni, L. Institutionalization in the elderly: the role of chronic diseases and dementia. Cross-sectional and longitudinal data from a population-based study. J Clin Epidemiol. 2001;54:795-801.CrossRefGoogle ScholarPubMed
31. Andersen-Ranberg, K, Vasegaard, L, Jeune, B. Dementia is not inevitable: a population-based study of Danish centenarians. J Gerontology B Psychol Sci Soc Sci. 2001;56:P152-P159.CrossRefGoogle Scholar
32. Anttila, T, Helkala, EL, Kivipelto, M, Hallikainen, M, Alhainen, K, Heinonen, H, et al. Midlife income, occupation, APOE status, and dementia: a population-based study. Neurology. 2002;59:887-893.CrossRefGoogle ScholarPubMed
33. Anttila, T, Helkala, EL, Viitanen, M, Kåreholt, I, Fratiglioni, L, Winblad, B, et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ. 2004;329:539.CrossRefGoogle ScholarPubMed
34. Arslantas, D, Ozbabalik, D, Metintas, S, Ozkan, S, Kalyoncu, C, Ozdemir, G, et al. Prevalence of dementia and associated risk factors in Middle Anatolia, Turkey. J Clin Neurosci. 2009;16:1455-1459.CrossRefGoogle ScholarPubMed
35. Banerjee, TK, Mukherjee, CS, Dutt, A, Shekhar, A, Hazra, A. Cognitive dysfunction in an urban Indian population: some observations. Neuroepidemiology. 2008;31:109-114.CrossRefGoogle Scholar
36. Benedetti, MD, Salviati, A, Filipponi, S, Manfredi, M, De Togni, L, Gomez Lira, M, et al. Prevalence of dementia and apolipoprotein e genotype distribution in the elderly of Buttapietra, Verona Province, Italy. Neuroepidemiology. 2002;21:74-80.CrossRefGoogle ScholarPubMed
37. Bennett, HP, Piguet, O, Grayson, DA, Creasey, H, Waite, LM, Broe, DA, et al. A 6-year study of cognition and spatial function in the demented and non-demented elderly: the Sydney Older Persons Study. Dement Geriatr Cogn Disord. 2003;16:181-186.CrossRefGoogle ScholarPubMed
38. Bermejo-Pareja, F, Benito-Leon, J, Vega, S, Olazarán, J, de Toledo, M, Díaz-Guzmán, J, et al. Consistency of clinical diagnosis of dementia in NEDICES: a population-based longitudinal study in Spain. J Geriatr Psychiatry Neurol. 2009;22:246-255.CrossRefGoogle ScholarPubMed
39. Borjesson-Hanson, A, Edin, E, Gislason, T, Skoog, I. The prevalence of dementia in 95 year olds. Neurology. 2004;63:2436-2438.CrossRefGoogle ScholarPubMed
40. Borroni, B, Alberici, A, Grassi, M, Rozzini, L, Turla, M, Zanetti, O, et al. Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia County, Italy. Alzheimer Dis Assoc Disord. 2011;25:341-344.CrossRefGoogle ScholarPubMed
41. Bottino, CMC, Azevedo, D Jr., Tatsch, M, Hototian, SR, Moscoso, MA, Folquitto, J, et al. Estimate of dementia prevalence in a community sample from São Paulo, Brazil. Dement Geriatr Cogn Disord. 2008;26:291-299.CrossRefGoogle Scholar
42. Camicioli, R, Willert, P, Lear, J, Grossmann, S, Kaye, J, Butterfield, P. Dementia in rural primary care practices in Lake County, Oregon. J Geriatr Psychiatry Neurol. 2000;13:87-92.CrossRefGoogle ScholarPubMed
43. Chen, TF, Chiu, MJ, Tang, LY, Chiu, YH, Chang, SF, Su, CL, et al. Institution type-dependent high prevalence of dementia in long-term care units. Neuroepidemiology. 2007;28:142-149.CrossRefGoogle ScholarPubMed
44. Chien, IC, Lin, YC, Chou, YJ, Lin, CH, Bih, SH, Lee, CH, et al. Treated prevalence and incidence of dementia among National Health Insurance enrolees in Taiwan, 1996-2003. J Geriatr Psychiatry Neurol. 2008;21:142-148.CrossRefGoogle Scholar
45. Corrada, MM, Brookmeyer, R, Berlau, D, Paganini-Hill, A, Kawas, CH. Prevalence of dementia after age 90: results from the 90+ study. Neurology. 2008;71:337-343.CrossRefGoogle ScholarPubMed
46. Cristina, S, Nicolosi, A, Hauser, WA, Leite, ML, Gerosa, E, Nappi, G. The prevalence of dementia and cognitive deficit in a rural population of 2442 residents in Northern Italy: a door-to-door survey. Eur J Neurol. 2001;8:595-600.CrossRefGoogle Scholar
47. Dahl, A, Berg, S, Nilsson, SE. Identification of dementia in epidemiological research: a study on the usefulness of various data sources. Aging Clin Exp Res. 2007;19:381-389.CrossRefGoogle ScholarPubMed
48. Das, SK, Biswas, A, Roy, J, Bose, P, Roy, T, Banerjee, TK, et al. Prevalence of major neurological disorders among a geriatric population in the metropolitan city of Kolkata. J Assoc Physicians India. 2008;56:175-181.Google ScholarPubMed
49. Das, SK, Biswas, A, Roy, T, Banerjee, TK, Mukherjee, CS, Raut, DK, et al. A random sample survey for prevalence of major neurological disorders in Kolkata. Indian J Med Res. 2006;124:163-172.Google ScholarPubMed
50. de Jesus Llibre, J, Fernandez, Y, Marcheco, B, Contreras, M, López, AM, Otero, M, et al. Prevalence of dementia and Alzheimer’s disease in a Havana municipality: A community-based study among elderly residents. MEDICC Rev. 2009;11:29-35.Google Scholar
51. De Ronchi, D, Berardi, D, Menchetti, M, Ferrari, G, Serretti, A, Dalmonte, E, et al. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord. 2005;19:97-105.CrossRefGoogle ScholarPubMed
52. de Silva, HA, Gunatilake, SB, Smith, AD. Prevalence of dementia in a semi-urban population in Sri Lanka: report from a regional survey. Int J Geriatr Psychiatry. 2003;18:711-715.CrossRefGoogle Scholar
53. Demirovic, J, Prineas, R, Loewenstein, D, Bean, J, Duara, R, Sevush, S, et al. Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol. 2003;13:472-478.CrossRefGoogle ScholarPubMed
54. Di Carlo, A, Baldereschi, M, Amaducci, L, Maggi, S, Origoletto, F, Scarlato, G, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability: the Italian Longitudinal Study on Aging. J Am Geriatr Soc. 2000;48:775-782.CrossRefGoogle ScholarPubMed
55. Feldman, H, Clarfield, AM, Brodsky, J, King, Y, Dwolatzky, T. An estimate of the prevalence of dementia among residents of long-term care geriatric institutions in the Jerusalem area. Int Psychogeriatr. 2006;18:643-652.CrossRefGoogle ScholarPubMed
56. Fish, M, Bayer, AJ, Gallacher, JEJ, Bell, T, Pickering, J, Pedro, S, et al. Prevalence and pattern of cognitive impairment in a community cohort of men in South Wales: methodology and findings from the Caerphilly Prospective Study. Neuroepidemiology. 2008;30:25-33.CrossRefGoogle Scholar
57. Fujishima, M, Kiyohara, Y. Incidence and risk factors of dementia in a defined elderly Japanese population: the Hisayama study. Ann N Y Acad Sci. 2002;977:1-8.CrossRefGoogle Scholar
58. Galasko, D, Salmon, D, Gamst, A, Olichney, J, Thal, LJ, Silbert, L, et al. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology. 2007;68:1772-1781.CrossRefGoogle ScholarPubMed
59. Ganguli, M, Chandra, V, Kamboh, MI, Johnston, JM, Dodge, HH, Thelma, BK, et al. Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia Study. Arch Neurol. 2000;57:824-830.CrossRefGoogle ScholarPubMed
60. Gascon-Bayarri, J, Rene, R, Del Barrio, JL, De Pedro-Cuesta, J, Ramón, JM, Manubens, JM, et al. Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study. Neuroepidemiology. 2007;28:224-234.CrossRefGoogle Scholar
61. Gavrila, D, Antunez, C, Tormo, MJ, Carles, R, García Santos, JM, Parrilla, G, et al. Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study. Acta Neurol. Scand. 2009;120:300-307.CrossRefGoogle ScholarPubMed
62. Gislason, TB, Sjogren, M, Larsson, L, Skoog, I. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population-based sample of 85 year olds. J Neurol Neurosurg Psychiatry. 2003;74:867-871.CrossRefGoogle Scholar
63. Gourie-Devi, M, Gururaj, G, Satishchandra, P, Subbakrishna, DK. Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas. Neuroepidemiology. 2004;23:261-268.CrossRefGoogle ScholarPubMed
64. Graham, JE, Rockwood, K, Beattie, BL, Eastwood, R, Gauthier, S, Tuokko, H, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793-1796.CrossRefGoogle Scholar
65. Guerchet, M, M’Belesso, P, Mouanga, AM, Bandzouzi, B, Tabo, A, Houinato, DS, et al. Prevalence of dementia in elderly living in two cities of Central Africa: the EDAC survey. Dement Geriatr Cogn Disord. 2010;30:261-268.CrossRefGoogle ScholarPubMed
66. Gureje, O, Ogunniyi, A, Kola, L. The profile and impact of probable dementia in a Sub-Saharan African community: Results from the Ibadan Study of Aging. J Psychosom Res. 2006;61:327-333.CrossRefGoogle Scholar
67. Gurvit, H, Emre, M, Tinaz, S, Bilgic, B, Hanagasi, H, Sahin, H, et al. The prevalence of dementia in an urban Turkish population. Am J Alzheimers Dis Other Demen. 2008;23:67-76.CrossRefGoogle Scholar
68. Hall, KS, Gao, S, Baiyewu, O, Lane, KA, Gureje, O, Shen, J, et al. Prevalence rates for dementia and Alzheimer’s disease in African Americans: 1992 versus 2001. Alzheimers Dement. 2009;5:227-233.CrossRefGoogle ScholarPubMed
69. Harvey, RJ, Skelton-Robinson, M, Rossor, MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry. 2003;74:1206-1209.CrossRefGoogle ScholarPubMed
70. Helmer, C, Peres, K, Letenneur, L, Guttiérez-Robledo, LM, Ramaroson, H, Barberger-Gateau, P, et al. Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity. Dement. Geriatr Cogn Disord. 2006;22:87-94.CrossRefGoogle ScholarPubMed
71. Herrera, E Jr., Caramelli, P, Silveira, ASB, Nitrini, R. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord. 2002;16:103-108.CrossRefGoogle Scholar
72. Ikeda, M, Fukuhara, R, Shigenobu, K, Hokoishi, K, Maki, N, Nebu, A, et al. Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry. 2004;75:146-148.Google ScholarPubMed
73. Ikeda, M, Hokoishi, K, Maki, N, Nebu, A, Tachibana, N, Komori, K, et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology. 2001;57:839-844.CrossRefGoogle ScholarPubMed
74. Ikejima, C, Yasuno, F, Mizukami, K, Sasaki, M, Tanimukai, S, Asada, T. Prevalence and causes of early-onset dementia in Japan: a population-based study. Stroke. 2009;40:2709-2714.CrossRefGoogle ScholarPubMed
75. Jacob, KS, Kumar, PS, Gayathri, K, Abraham, S, Prince, MJ. The diagnosis of dementia in the community. Int Psychogeriatr. 2007;19:669-678.CrossRefGoogle Scholar
76. Jhoo, JH, Kim, KW, Huh, Y, Lee, SB, Park, JH, Lee, JJ, et al. Prevalence of dementia and its subtypes in an elderly urban Korean population: results from the Korean Longitudinal Study on Health And Aging (KLoSHA). Dement Geriatr Cogn Disord. 2008;26:270-276.CrossRefGoogle Scholar
77. Jitapunkul, S, Chansirikanjana, S, Thamarpirat, J. Undiagnosed dementia and value of serial cognitive impairment screening in developing countries: a population-based study. Geriatr Gerontol Int. 2009;9:47-53.CrossRefGoogle ScholarPubMed
78. Jitapunkul, S, Kunanusont, C, Phoolcharoen, W, Suriyawongpaisal, P. Prevalence estimation of dementia among Thai elderly: a national survey. J Med Assoc Thai. 2001;84:461-467.Google ScholarPubMed
79. Juva, K, Verkkoniemi, A, Viramo, P, Polvikoski, T, Kainulainen, K, Kontula, K, et al. Apolipoprotein E, cognitive function, and dementia in a general population aged 85 years and over. Int Psychogeriatr. 2000;12:379-387.CrossRefGoogle Scholar
80. Kahana, E, Galper, Y, Zilber, N, Korczyn, AD. Epidemiology of dementia in Ashkelon: the influence of education. J Neurol. 2003;250:424-428.CrossRefGoogle ScholarPubMed
81. Kim, J, Jeong, I, Chun, JH, Lee, S. The prevalence of dementia in a metropolitan city of South Korea. Int J Geriatr Psychiatry. 2003;18:617-622.CrossRefGoogle Scholar
82. Kivipelto, M, Helkala, EL, Laakso, M, Hänninen, T, Hallikainen, M, Alhainen, K, et al. Apolipoprotein E e4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med. 2002;137:149-155.CrossRefGoogle Scholar
83. Kivipelto, M, Helkala, EL, Laakso, M, Laakso, MP, Hallikainen, M, Alhainen, K, et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population-based study. BMJ. 2001;322:1447-1451.CrossRefGoogle ScholarPubMed
84. Landi, F, Russo, A, Cesari, M, Barillaro, C, Onder, G, Zamboni, V, et al. The ilSIRENTE study: a prospective cohort study on persons aged 80 years and older living in a mountain community of Central Italy. Aging Clin Exp Res. 2005;17:486-493.CrossRefGoogle Scholar
85. Langa, KM, Plassman, BL, Wallace, RB, Herzog, AR, Heeringa, SG, Ofstedal, MB, Burke, , et al. The Aging, Demographics, and Memory Study: study design and methods. Neuroepidemiology. 2005;25:181-191.CrossRefGoogle ScholarPubMed
86. Lee, DY, Lee, JH, Ju, YS, Lee, KU, Kim, KW, Jhoo, JH, et al. The prevalence of dementia in older people in an urban population of Korea: the Seoul study. J Am Geriatr Soc. 2002;50:1233-1239.CrossRefGoogle Scholar
87. Li, G, Rhew, IC, Shofer, JB, Kukull, WA, Breitner, JC, Peskind, E, et al. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc. 2007;55:1161-1167.CrossRefGoogle ScholarPubMed
88. Livingston, G, Leavey, G, Kitchen, G, Manela, M, Sembhi, S, Katona, C. Mental health of migrant elders: the Islington study. Br J Psychiatry. 2001;179:361-366.CrossRefGoogle ScholarPubMed
89. Llibre Rodriguez, J, Valhuerdi, A, Sanchez, II, Reyna, C, Guerra, MA, Copeland, JR, et al. The prevalence, correlates and impact of dementia in Cuba: a 10/66 group population-based survey. Neuroepidemiology. 2008;31:243-251.CrossRefGoogle ScholarPubMed
90. Llibre Rodriguez, JJ, Ferri, CP, Acosta, D, Guerra, M, Huang, Y, Jacob, KS, et al. Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey. Lancet. 2008;372:464-474.CrossRefGoogle ScholarPubMed
91. Lovheim, H, Karlsson, S, Gustafson, Y. The use of central nervous system drugs and analgesics among very old people with and without dementia. Pharmacoepidemiol Drug Saf. 2008;17:912-918.CrossRefGoogle Scholar
92. Luck, T, Luppa, M, Weber, S, Matschinger, H, Glaesmer, H, Konig, HH, et al. Time until institutionalization in incident dementia cases: results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). Neuroepidemiology. 2008;31:100-108.CrossRefGoogle Scholar
93. Magaziner, J, German, P, Zimmerman, SI, Hebel, JR, Burton, L, Gruber-Baldini, AL, et al. The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: diagnosis by expert panel. Epidemiology of Dementia in Nursing Homes Research Group. Gerontologist. 2000;40:663-672.CrossRefGoogle Scholar
94. Maneno, MK, Lee, E, Wutoh, AK, Zuckerman, IH, Jackson, P, Lombardo, FA, et al. National patterns of dementia treatment among elderly ambulatory patients. J Natl Med Assoc. 2006;98:430-435.Google ScholarPubMed
95. Manton, KC, Gu, XL, Ukraintseva, SV. Declining prevalence of dementia in the U.S. elderly population. Adv Gerontol. 2005;16:30-37.Google ScholarPubMed
96. Martens, PJ, Fransoo, R, Burland, E, Burchill, C, Prior, HJ, Ekuma, O, et al. Prevalence of mental illness and its impact on the use of home care and nursing homes: a population-based study of older adults in Manitoba. Can J Psychiatry. 2007;52:581-590.CrossRefGoogle Scholar
97. Mathuranath, PS, Cherian, PJ, Mathew, R, Kumar, S, George, A, Alexander, A, et al. Dementia in Kerala, South India: prevalence and influence of age, education and gender. Int J Geriatr Psychiatry. 2010;25:290-297.CrossRefGoogle ScholarPubMed
98. Meguro, K, Ishii, H, Yamaguchi, S, Ishizaki, J, Shimada, M, Sato, M, et al. Prevalence of dementia and dementing diseases in Japan: the Tajiri project. Arch Neurol. 2002;59:1109-1114.CrossRefGoogle ScholarPubMed
99. Mehlig, K, Skoog, I, Guo, X, Schütze, M, Gustafson, D, Waern, M, et al. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg. Am J Epidemiol. 2008;167:684-691.CrossRefGoogle ScholarPubMed
100. Molero, AE, Pino-Ramirez, G, Maestre, GE. High prevalence of dementia in a Caribbean population. Neuroepidemiology. 2007;29:107-112.CrossRefGoogle Scholar
101. Nabalamba, A, Patten, SB. Prevalence of mental disorders in a Canadian household population with dementia. Can J Neurol Sci. 2010;37:186-194.CrossRefGoogle Scholar
102. Ng, TP, Leong, T, Chiam, PC, Kua, EH. Ethnic variations in dementia: the contributions of cardiovascular, psychosocial and neuropsychological factors. Dement Geriatr Cogn Disord. 2010;29:131-138.CrossRefGoogle ScholarPubMed
103. Nunes, B, Silva, RD, Cruz, VT, Roriz, JM, Pais, J, Silva, MC. Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal. BMC Neurol. 2010;10:42.CrossRefGoogle Scholar
104. Perkins, AJ, Hui, SL, Ogunniyi, A, Gureje, O, Baiyewu, O, Unverzagt, FW, et al. Risk of mortality for dementia in a developing country: the Yoruba in Nigeria. Int J Geriatr Psychiatry. 2002;17:566-573.CrossRefGoogle Scholar
105. Plassman, BL, Langa, KM, Fisher, GG, Heeringa, SG, Weir, DR, Ofstedal, MB, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125-132.CrossRefGoogle ScholarPubMed
106. Polvikoski, T, Sulkava, R, Myllykangas, L, Notkola, IL, Niinistö, L, Verkkoniemi, A, et al. Prevalence of Alzheimer’s disease in very elderly people: a prospective neuropathological study. Neurology. 2001;56:1690-1696.CrossRefGoogle ScholarPubMed
107. Prince, M, Llibre Rodriguez, J, Noriega, L, Lopez, A, Acosta, D, Albanese, E, et al. The 10/66 Dementia Research Group’s fully operationalised DSM–IV dementia computerized diagnostic algorithm, compared with the 10/66 dementia algorithm and a clinician diagnosis: a population validity study. BMC Public Health. 2008;8:1-12.CrossRefGoogle Scholar
108. Rahkonen, T, Eloniemi-Sulkava, U, Rissanen, S, Vatanen, A, Viramo, P, Sulkava, R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry. 2003;74:720-724.CrossRefGoogle ScholarPubMed
109. Riedel-Heller, SG, Busse, A, Aurich, C, Matschinger, H, Angermeyer, MC. Prevalence of dementia according to DSM–III–R and ICD–10: results of the Leipzig Longitudinal Study of the Aged (LEILA75+) Part 1. Br J Psychiatry. 2001;179:250-254.CrossRefGoogle ScholarPubMed
110. Riedel-Heller, SG, Schork, A, Matschinger, H, Angermeyer, MC. Recruitment procedures and their impact on the prevalence of dementia: results from the Leipzig Longitudinal Study of the Aged (LEILA75+). Neuroepidemiology. 2000;19:130-140.CrossRefGoogle Scholar
111. Rockwood, K, Wentzel, C, Hachinski, V, Hogan, DB, MacKnight, C, McDowell, I. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology. 2000;54:447-451.CrossRefGoogle ScholarPubMed
112. Rosenblatt, A, Samus, QM, Steele, CD, Baker, AS, Harper, MG, Brandt, J, et al. The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. J Am Geriatr Soc. 2004;52:1618-1625.CrossRefGoogle ScholarPubMed
113. Rovio, S, Kareholt, I, Helkala, EL, Viitanen, M, Winblad, B, Tuomilehto, J, et al. Leisure-time physical activity and the risk of dementia and Alzheimer’s disease. Lancet Neurol. 2005;4:705-711.CrossRefGoogle ScholarPubMed
114. Sahadevan, S, Saw, SM, Gao, W, Tan, LC, Chin, JJ, Hong, CY, et al. Ethnic differences in Singapore’s dementia prevalence: the stroke, Parkinson’s disease, epilepsy, and dementia in Singapore study. J Am Geriatr Soc. 2008;56:2061-2068.CrossRefGoogle ScholarPubMed
115. Sanderson, M, Benjamin, JT, Lane, MJ, Cornman, CB, Davis, DR. Application of capture–recapture methodology to estimate the prevalence of dementia in South Carolina. Ann Epidemiol. 2003;13:518-524.CrossRefGoogle ScholarPubMed
116. Scazufca, M, Menezes, PR, Vallada, HP, Crepaldi, AL, Pastor-Valero, M, Coutinho, LM, et al. High prevalence of dementia among older adults from poor socioeconomic backgrounds in São Paulo, Brazil. Int Psychogeriatr. 2008;20:394-405.CrossRefGoogle ScholarPubMed
117. Sekita, A, Ninomiya, T, Tanizaki, Y, Doi, Y, Hata, J, Yonemoto, K, et al. Trends in prevalence of Alzheimer’s disease and vascular dementia in a Japanese community: the Hisayama Study. Acta Psychiatr Scand. 2010;122:319-325.CrossRefGoogle Scholar
118. Senanarong, V, Jamjumrus, P, Harnphadungkit, K, Vannasaeng, S, Udompunthurak, S, Prayoonwiwat, N, et al. Risk factors for dementia and impaired cognitive status in Thai elderly. J Med Assoc Thai. 2001;84:468-474.Google ScholarPubMed
119. Senanarong, V, Poungvarin, N, Sukhatunga, K, Prayoonwiwat, N, Chaisewikul, R, Petchurai, R, et al. Cognitive status in the community dwelling Thai elderly. J Med Assoc Thai. 2001;84:408-416.Google ScholarPubMed
120. Shaji, S, Bose, S, Verghese, A. Prevalence of dementia in an urban population in Kerala, India. Br J Psychiatry. 2005;187:90.CrossRefGoogle Scholar
121. Silver, MH, Jilinskaia, E, Perls, TT. Cognitive functional status of age-confirmed centenarians in a population-based study. J Gerontology B Psychol Sci Soc Sci. 2001;56:P134-P140.CrossRefGoogle ScholarPubMed
122. Sousa, RM, Ferri, CP, Acosta, D, Albanese, E, Guerra, M, Huang, Y, et al. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Lancet. 2009;374:1821-1830.CrossRefGoogle ScholarPubMed
123. Spada, RS, Stella, G, Calabrese, S, Bosco, P, Anello, G, Guéant-Rodriguez, RM, et al. Prevalence of dementia in mountainous village of Sicily. J Neurol Sci. 2009;283:62-65.CrossRefGoogle ScholarPubMed
124. Stevens, T, Livingston, G, Kitchen, G, Manela, M, Walker, Z, Katona, C. Islington study of dementia subtypes in the community. Br J Psychiatry. 2002;180:270-276.CrossRefGoogle Scholar
125. Suh, GH, Kim, JK, Cho, MJ. Community study of dementia in the older Korean rural population. Aust N Z J Psychiatry. 2003;37:606-612.Google ScholarPubMed
126. van Exel, E, de Craen, AJM, Gussekloo, J, Houx, P, Bootsma-van der Wiel, A, Macfarlane, PW, et al. Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol. 2002;51:716-721.CrossRefGoogle ScholarPubMed
127. Vas, CJ, Pinto, C, Panikker, D, Noronha, S, Deshpande, N, Kulkarni, L, et al. Prevalence of dementia in an urban Indian population. Int Psychogeriatr. 2001;13:439-450.CrossRefGoogle Scholar
128. von Heideken Wagert, P, Gustavsson, JM, Lundin-Olsson, L, Kallin, K, Nygren, B, Lundman, B, et al. Health status in the oldest old: age and sex differences in the Umea 85+ Study. Aging Clin Exp Res. 2006;18:116-126.CrossRefGoogle ScholarPubMed
129. Wada-Isoe, K, Uemura, Y, Suto, Y, Doi, K, Imamura, K, Hayashi, A, et al. Prevalence of dementia in the rural island town of Ama-cho, Japan. Neuroepidemiology. 2009;32:101-106.CrossRefGoogle ScholarPubMed
130. Wakutani, Y, Kusumi, M, Wada, K, Kawashima, M, Ishizaki, K, Mori, M, et al. Longitudinal changes in the prevalence of dementia in a Japanese rural area. Psychogeriatrics. 2007;7:150-154.CrossRefGoogle Scholar
131. Wancata, J, Borjesson-Hanson, A, Ostling, S, Sjogren, K, Skoog, I. Diagnostic criteria influence dementia prevalence. Am J Geriatr Psychiatry. 2007;15:1034-1045.CrossRefGoogle ScholarPubMed
132. Wangtongkum, S, Sucharitkul, P, Silprasert, N, Inthrachak, R. Prevalence of dementia among population age over 45 years in Chiang Mai, Thailand. J Med Assoc Thai. 2008;91:1685-1690.Google ScholarPubMed
133. Wertman, E, Brodsky, J, King, Y, Bentur, N, Chekhmir, S. An estimate of the prevalence of dementia among community-dwelling elderly in Israel. Dement Geriatr Cogn Disord. 2007;24:294-299.CrossRefGoogle ScholarPubMed
134. Xu, W, Qiu, C, Gatz, M, Pedersen, NL, Johansson, B, Fratiglioni, L. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes. 2009;58:71-77.CrossRefGoogle ScholarPubMed
135. Yamada, T, Hattori, H, Miura, A, Tanabe, M, Yamori, Y. Prevalence of Alzheimer’s disease, vascular dementia and dementia with Lewy bodies in a Japanese population. Psychiatry Clin Neurosci. 2001;55:21-25.CrossRefGoogle Scholar
136. Zhao, Q, Zhou, B, Ding, D, Guo, Q, Hong, Z. Prevalence, mortality, and predictive factors on survival of dementia in Shanghai, China. Alzheimer Dis Assoc Disord. 2010;24:151-158.CrossRefGoogle ScholarPubMed
137. Zhou, DF, Wu, CS, Qi, H, Fan, JH, Sun, XD, Como, P, et al. Prevalence of dementia in rural China: impact of age, gender and education. Acta Neurol Scand. 2006;114:273-280.CrossRefGoogle Scholar
138. Andreasen, N, Blennow, K, Sjodin, C, Winblad, B, Svardsudd, K. Prevalence and incidence of clinically diagnosed memory impairments in a geographically defined general population in Sweden. The Pitea Dementia Project. Neuroepidemiology. 1999;18:144-155.CrossRefGoogle Scholar
139. Arai, A, Katsumata, Y, Konno, K, Tamashiro, H. Sociodemographic factors associated with incidence of dementia among senior citizens of a small town in Japan. Care Manag J. 2004;5:159-165.CrossRefGoogle ScholarPubMed
140. Benito-Leon, J, Bermejo-Pareja, F, Vega, S, Louis, ED. Total daily sleep duration and the risk of dementia: a prospective population-based study. Eur J Neurol. 2009;16:990-997.CrossRefGoogle ScholarPubMed
141. Bermejo-Pareja, F, Benito-Leon, J, Vega, S, Medrano, MJ, Roman, GC, Neurological Disorders Study Group in Central Spain. Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci. 2008;264:63-72.CrossRefGoogle ScholarPubMed
142. Cornelius, C, Fastbom, J, Winblad, B, Viitanen, M. Aspirin, NSAIDs, risk of dementia, and influence of the apolipoprotein E epsilon 4 allele in an elderly population. Neuroepidemiology. 2004;23:135-143.CrossRefGoogle Scholar
143. Di Carlo, A, Baldereschi, M, Amaducci, L, Lepore, V, Bracco, L, Maggi, S, et al. Incidence of dementia, Alzheimer’s disease, and vascular dementia in Italy: the ILSA Study. J Am Geriatr Soc. 2002;50:41-48.CrossRefGoogle ScholarPubMed
144. Edland, SD, Rocca, WA, Petersen, RC, Cha, RH, Kokmen, E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002;59:1589-1593.CrossRefGoogle Scholar
145. Fitzpatrick, AL, Kuller, LH, Ives, DG, Lopez, OL, Jagust, W, Breitner, JC, et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52:195-204.CrossRefGoogle ScholarPubMed
146. Forti, P, Pisacane, N, Rietti, E, Lucicesare, A, Olivelli, V, Mariani, E, et al. Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc. 2010;58:487-492.CrossRefGoogle ScholarPubMed
147. Fuhrer, R, Dufouil, C, Dartigues, JF, PAQUID Study. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J Am Geriatr Soc. 2003;51:1055-1063.CrossRefGoogle ScholarPubMed
148. Ganguli, M, Dodge, HH, Chen, P, Belle, S, DeKosky, ST. Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology. 2000;54:1109-1116.CrossRefGoogle Scholar
149. Garre-Olmo, J, Genis Batlle, D, del Mar Fernandez, M, Marquez Daniel, F, de Eugenio Huélamo, R, Casadevall, T, et al. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology. 2010;75:1249-1255.CrossRefGoogle Scholar
150. Hendrie, HC, Ogunniyi, A, Hall, KS, Baiyewu, O, Unverzagt, FW, Gureje, O, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001;285:739-747.CrossRefGoogle ScholarPubMed
151. Kawas, C, Gray, S, Brookmeyer, R, Fozard, J, Zonderman, A. Age-specific incidence rates of Alzheimer’s disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000;54:2072-2077.CrossRefGoogle ScholarPubMed
152. Knopman, DS, Petersen, RC, Cha, RH, Edland, SD, Rocca, WA. Incidence and causes of nondegenerative nonvascular dementia: a population-based study. Arch Neurol. 2006;63:218-221.CrossRefGoogle ScholarPubMed
153. Knopman, DS, Petersen, RC, Edland, SD, Cha, RH, Rocca, WA. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology. 2004;62:506-508.CrossRefGoogle ScholarPubMed
154. Knopman, DS, Rocca, WA, Cha, RH, Edland, SD, Kokmen, E. Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol. 2002;59:1605-1610.CrossRefGoogle ScholarPubMed
155. Knopman, DS, Rocca, WA, Cha, RH, Edland, SD, Kokmen, E. Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol. 2003;60:85-90.CrossRefGoogle ScholarPubMed
156. Kukull, WA, Higdon, R, Bowen, JD, McCormick, WC, Teri, L, Schellenberg, GD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol. 2002;59:1737-1746.CrossRefGoogle ScholarPubMed
157. Kuller, LH, Lopez, OL, Jagust, WJ, Becker, JT, DeKosky, ST, Lyketsos, C, et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology. 2005;64:1548-1552.CrossRefGoogle ScholarPubMed
158. Larrieu, S, Letenneur, L, Helmer, C, Dartigues, JF, Barberger-Gateau, P. Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging. 2004;8:150-154.Google ScholarPubMed
159. Lopez, OL, Kuller, LH, Becker, JT, Jagust, WJ, DeKosky, ST, Fitzpatrick, A, et al. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Neurology. 2005;64:1539-1547.CrossRefGoogle ScholarPubMed
160. Lopez-Pousa, S, Vilalta-Franch, J, Llinas-Regla, J, Garre-Olmo, J, Roman, GC. Incidence of dementia in a rural community in Spain: the Girona cohort study. Neuroepidemiology. 2004;23:170-177.CrossRefGoogle Scholar
161. Matsui, Y, Tanizaki, Y, Arima, H, Yonemoto, K, Doi, Y, Ninomiya, T, et al. Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry. 2009;80:366-370.CrossRefGoogle Scholar
162. Matthews, F, Brayne, C, Medical Research Council Cognitive Function and Ageing Study Investigators. The incidence of dementia in England and Wales: findings from the five identical sites of the MRC CFA Study. PLoS Med. 2005;2:e193. Erratum appears in PLoS Med. 2005 Oct2(10):e389.CrossRefGoogle Scholar
163. McDowell, I, Xi, G, Lindsay, J, Tierney, M. Mapping the connections between education and dementia. J Clin Exp Neuropsychol. 2007;29:127-141.CrossRefGoogle ScholarPubMed
164. Mercy, L, Hodges, JR, Dawson, K, Barker, RA, Brayne, C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology. 2008;71:1496-1499.CrossRefGoogle ScholarPubMed
165. Miech, RA, Breitner, JCS, Zandi, PP, Khachaturian, AS, Anthony, JC, Mayer, L. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology. 2002;58:209-218.CrossRefGoogle ScholarPubMed
166. Nitrini, R, Caramelli, P, Herrera, E Jr., Bahia, VS, Caixeta, LF, Radanovic, M, et al. Incidence of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord. 2004;18:241-246.Google Scholar
167. Piguet, O, Grayson, DA, Creasey, H, Bennett, HP, Brooks, WS, Waite, LM, et al. Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuroepidemiology. 2003;22:165-171.CrossRefGoogle ScholarPubMed
168. Polvikoski, T, Sulkava, R, Rastas, S, Sutela, A, Niinistö, L, Notkola, IL, et al. Incidence of dementia in very elderly individuals: a clinical, neuropathological and molecular genetic study. Neuroepidemiology. 2006;26:76-82.CrossRefGoogle ScholarPubMed
169. Ravaglia, G, Forti, P, Lucicesare, A, Pisacane, N, Rietti, E, Bianchin, M, et al. Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology. 2008;70:1786-1794.CrossRefGoogle ScholarPubMed
170. Ravaglia, G, Forti, P, Maioli, F, Martelli, M, Servadei, L, Brunetti, N, et al. Incidence and etiology of dementia in a large elderly Italian population. Neurology. 2005;64:1525-1530.CrossRefGoogle Scholar
171. Ravaglia, G, Forti, P, Maioli, F, Montesi, F, Rietti, E, Pisacane, N, et al. Risk factors for dementia: data from the Conselice study of brain aging. Arch Gerontol Geriatr. 2007;44(Suppl 1):311-320.CrossRefGoogle ScholarPubMed
172. Riedel-Heller, SG, Busse, A, Aurich, C, Matschinger, H, Angermeyer, MC. Incidence of dementia according to DSM–III–R and ICD–10: results of the Leipzig Longitudinal Study of the Aged (LEILA75+), Part 2. Br J Psychiatry. 2001;179:255-260.CrossRefGoogle ScholarPubMed
173. Ruitenberg, A, Ott, A, van Swieten, JC, Hofman, A, Breteler, MM. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001;22:575-580.CrossRefGoogle Scholar
174. Samieri, C, Feart, C, Letenneur, L, Dartigues, JF, Pérès, K, Auriacombe, S, et al. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr. 2008;88:714-721.Google ScholarPubMed
175. Seshadri, S, Beiser, A, Selhub, J, Jacques, PF, Rosenberg, IH, D’Agostino, RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s Disease. New Engl J Med. 2002;346:476-483.CrossRefGoogle ScholarPubMed
176. Simons, LA, Simons, J, McCallum, J, Friedlander, Y. Lifestyle factors and risk of dementia: Dubbo Study of the elderly. Med J Aust. 2006;184:68-70.Google ScholarPubMed
177. Tyas, SL, Tate, RB, Wooldrage, K, Manfreda, J, Strain, LA. Estimating the incidence of dementia: the impact of adjusting for subject attrition using health care utilization data. Ann Epidemiol. 2006;16:477-484.CrossRefGoogle ScholarPubMed
178. Vermeer, SE, Prins, ND, den Heijer, T, Hofman, A, Koudstaal, PJ, Breteler, MM. Silent brain infarcts and the risk of dementia and cognitive decline. New Engl J Med. 2003;348:1215-1222.CrossRefGoogle ScholarPubMed
179. Waite, LM, Broe, GA, Grayson, DA, Creasey, H. The incidence of dementia in an Australian community population: the Sydney Older Persons Study. Int J Geriatr Psychiatry. 2001;16:680-689.CrossRefGoogle Scholar
180. Lopez, OL, Kuller, LH, Fitzpatrick, A, Ives, D, Becker, JT, Beauchamp, N. Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003;22:1-12.CrossRefGoogle ScholarPubMed
181. Meguro, K, Ishii, H, Kasuya, M, Akanuma, K, Meguro, M, Kasai, M, et al. Incidence of dementia and associated risk factors in Japan: The Osaki–Tajiri Project. J Neurol Sci. 2007;260:175-182.CrossRefGoogle ScholarPubMed
182. Phung, TKT, Waltoft, BL, Kessing, LV, Mortensen, PB, Waldemar, G. Time trend in diagnosing dementia in secondary care. Dement Geriatr Cogn Disord. 2010;29:146-153.CrossRefGoogle ScholarPubMed
183. Zuliani, G, Cavalieri, M, Galvani, M, Volpato, S, Cherubini, A, Bandinelli, S, et al. Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly: the InChianti study. J Gerontol A Biol Sci Med Sci. 2010;65:559-564.CrossRefGoogle ScholarPubMed
184. Hurd, MD, Martorell, P, Langa, K. Future monetary costs of dementia in the United States under alternative dementia prevalence scenarios. J Popul Ageing. 2015;8:101-112.CrossRefGoogle ScholarPubMed
185. Prince, M, Bryce, R, Albanese, E, Wimo, A, Ribeiro, W, Ferri, CP. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimers Dement. 2013;9(63-75):e62.CrossRefGoogle Scholar
186. Catindig, JA, Venketasubramanian, N, Ikram, MK, Chen, C. Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. J Neurol Sci. 2012;321:11-16.CrossRefGoogle ScholarPubMed
187. Dong, MJ, Peng, B, Lin, XT, Zhao, J, Zhou, YR, Wang, RH. The prevalence of dementia in the People’s Republic of China: a systematic analysis of 1980-2004 studies. Age Ageing. 2007;36:619-624.CrossRefGoogle ScholarPubMed
188. Zhang, Y, Xu, Y, Nie, H, Lei, T, Wu, Y, Zhang, L, et al. Prevalence of dementia and major dementia subtypes in the Chinese populations: a meta-analysis of dementia prevalence surveys, 1980-2010. J Clin Neurosci. 2012;19:1333-1337.CrossRefGoogle ScholarPubMed
189. Erkinjuntti, T, Ostbye, T, Steenhuis, R, Hachinski, V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667-1674.CrossRefGoogle ScholarPubMed
190. Pringsheim, T, Jette, N, Frolkis, A, Steeves, TD. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014;29:1583-1590.CrossRefGoogle ScholarPubMed
191. Pringsheim, T, Wiltshire, K, Day, L, Dykeman, J, Steeves, T, Jette, N. The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Mov Disord. 2012;27:1083-1091.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1 Study flow diagram.

Figure 1

Table 1 Studies Reporting on the Prevalence of Dementia

Figure 2

Table 2 Studies Reporting on the Incidence Rate of Dementia

Figure 3

Table 3 Studies Reporting on the Incidence Proportion of Dementia

Figure 4

Figure 2 Pooled point prevalence of dementia.

Figure 5

Figure 3 Pooled period prevalence of dementia.

Figure 6

Figure 4 Pooled incidence proportion of dementia.

Figure 7

Figure 5 Pooled incidence rate of dementia.

Figure 8

Table 4 Quality assessment scores of dementia incidence and prevalence studies

You have Access
Open access
68
Cited by